Plain-English translation of NCT07231679 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a new medication called to see if it is safe and how your body handles it. Researchers will give some participants the medication (either as a single dose or multiple doses over time) and others a placebo (a harmless saline solution), and carefully monitor everyone for any side effects or tolerability issues.
Chronic kidney disease related to diabetes is a serious condition that damages the kidneys over time. This trial is exploring whether this new treatment could be a safe option for people living with this condition.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic multiple times and may need to stay overnight at the facility. During your visits, you will receive injections (either under the skin or into a vein) of either the new medication or placebo. Researchers will monitor you closely with blood tests, urine tests, and check-ins to watch for any side effects and see how your body responds to the treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States
Australia